Darya Bubman, PhD

Licensing Officer, Engagement & Opportunity Development
Office of Technology Management
+1 415 237-1585

Darya joined the Office of Technology Management (OTM) in November 2011. Her responsibilities include technology management, licensing and outgoing material transfer agreements. Darya earned a B.A. degree in Biochemistry from Cornell University in Ithaca, N.Y. and a Ph.D. in Pharmacology from the Weill Cornell Graduate School of Medical Sciences in New York City. She conducted her doctoral work in the laboratory of Dr. Ethel Cesarman, studying deregulation of cancer signaling pathways by the Kaposi’s sarcoma-associated herpesvirus (KSHV) in primary effusion lymphoma. Following her graduate studies, Darya became an AAAS Science and Technology Policy Fellow and worked at the U.S. State Department in the Intellectual Property Office on international issues related to biomedical IP, innovation, and technology transfer. Prior to joining the OTM, she worked as a Technology Partnerships Manager at the NASA Ames Research Center located at Moffett Field, CA. Darya has a strong background in virology, oncology, pharmacology and molecular biology.

Darya is passionate about working with UCSF faculty and staff to transfer novel UCSF biomedical technologies from bench to bedside.


Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome.

American journal of clinical pathology

Czuchlewski DR, Csernus B, Bubman D, Hyjek E, Martin P, Chadburn A, Knowles DM, Cesarman E

Pathogenesis of Kaposi's sarcoma.

Hematology/oncology clinics of North America

Bubman D, Cesarman E

Role of a novel soluble nucleotide phospho-hydrolase from sheep plasma in inhibition of platelet reactivity: hemostasis, thrombosis, and vascular biology.

The Journal of laboratory and clinical medicine

Birk AV, Bubman D, Broekman MJ, Robertson HD, Drosopoulos JH, Marcus AJ, Szeto HH